Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Disclosure

Conflict of interest

Last updated Nov 2026

Alan Tan, MD, is Vice President of MRD Research and Clinical Strategy at Tempus and an Associate Professor of Medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center. He is a board-certified medical oncologist at Vanderbilt-Ingram Cancer Center.

Views on MRD Watch are his own. They are not those of Tempus or Vanderbilt. The site is not medical advice, and it is not affiliated with any employer, journal, society, or company named in the updates.

The same facts are on the about page. This page does not list pay, equity, consulting fees, or speaking fees.

TODO for Alan: add any other relationships you want named here, such as consulting, speaking, or research support. Do not invent amounts or agreements on this page.

How items are chosen is on the editorial policy.